Featured Research

from universities, journals, and other organizations

How Embryonic Livers Store Energy

Date:
February 27, 2008
Source:
American Society for Biochemistry and Molecular Biology
Summary:
Researchers have uncovered how embryonic livers accumulate an important energy molecule even though they lacks the key enzyme responsible. In adults, the liver stores glycogen, a sugar polymer that provides a steady supply of blood glucose when needed (e.g. during fasting). Glycogen production is controlled by an enzyme called glucokinase (GK), and mutations resulting in too much or too little GK will lead to hypo- and hyper-glycemia, respectively.

Researchers have uncovered how embryonic livers accumulate an important energy molecule even though they lacks the key enzyme responsible.

In adults, the liver stores glycogen, a sugar polymer that provides a steady supply of blood glucose when needed (e.g. during fasting). Glycogen production is controlled by an enzyme called glucokinase (GK), and mutations resulting in too much or too little GK will lead to hypo- and hyper-glycemia, respectively.

One interesting biological mystery has been that embryonic livers can store plenty of glycogen, yet they don't produce any GK; the liver only starts making this enzyme after newborns drink their first carbohydrate-rich milk.

Joan Guinovart and colleagues found that embryonic mouse livers circumvent the lack of GK by greatly overproducing (~200 fold higher than adult liver) another enzyme known as hexokinase (HK). Such as high amount is necessary because while HK can make glycogen, it's really inefficient.

However, unlike GK, HK makes glycogen independent of blood-glucose levels, and the researchers confirmed this by fasting pregnant mice and observing the embryonic livers did not alter their glycogen accumulation.

Thus, by using HK, embryos safeguard their glycogen production from any changes in maternal diet to ensure abundant storage. This is critical since glycogen is a newborn's principal source of energy in the critical time between birth and first milk meal.

This research was recently published in the Journal Of Biological Chemistry.


Story Source:

The above story is based on materials provided by American Society for Biochemistry and Molecular Biology. Note: Materials may be edited for content and length.


Cite This Page:

American Society for Biochemistry and Molecular Biology. "How Embryonic Livers Store Energy." ScienceDaily. ScienceDaily, 27 February 2008. <www.sciencedaily.com/releases/2008/02/080222143823.htm>.
American Society for Biochemistry and Molecular Biology. (2008, February 27). How Embryonic Livers Store Energy. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2008/02/080222143823.htm
American Society for Biochemistry and Molecular Biology. "How Embryonic Livers Store Energy." ScienceDaily. www.sciencedaily.com/releases/2008/02/080222143823.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins